NCT06494579 2025-12-16
Lamivudine for Solid Tumors
Icahn School of Medicine at Mount Sinai
Phase 1/2 Active not recruiting
Clinical Trials
13 trialsNCT04696575 2025-12-15
Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer
Roswell Park Cancer Institute
Phase 2 Recruiting
NCT06428045 2025-06-22
STARLITE
University of Miami
Phase 1 Recruiting
NCT03144804 2024-06-06
A Phase 2 Study of Lamivudine in Patients With p53 Mutant Metastatic Colorectal Cancer
Massachusetts General Hospital
Phase 2 Completed
NCT03528941 2022-05-12
LLC1618
Gruppo Italiano Malattie EMatologiche dell'Adulto
Completed
NCT01936233 2019-08-05
Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery
Fudan University
Phase 3 Unknown
NCT01580202 2017-06-29
Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine
Seoul National University Hospital
Phase 3 Completed
NCT00455091 2017-04-28
A Phase III Study in Post-operative HBV-related Hepatocellular Carcinoma
National Health Research Institutes, Taiwan
Terminated
NCT01528865 2016-03-11
Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma
University of Michigan Rogel Cancer Center
Phase 1/2 Withdrawn
NCT01210287 2014-01-08
IHBVRL
Fudan University
Phase 2/3 Unknown
NCT01914744 2013-08-02
Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL
Fudan University
Phase 2 Unknown
NCT00555334 2009-04-01
LAM-RFA
Sun Yat-sen University
Phase 4 Unknown
NCT00768157 2009-02-09
Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma
Sun Yat-sen University
Phase 4 Unknown